Curis | CRIS - Current Liabilities


Curis reported $14.08M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
CSL USD 4.61B 207M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Takeda JPY 2.61T 470.53B Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
Verastem USD 72.27M 12.56M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025